Department of Cardiology, Atlanta VA Medical Center, Decatur, GA, USA.
Department of Internal Medicine, Nassau University Medical Center, East Meadow, NY, USA.
Int J Cardiol. 2019 Apr 15;281:49-55. doi: 10.1016/j.ijcard.2019.01.074. Epub 2019 Jan 25.
We aimed to analyze the burden and predictors of arrhythmias and in-hospital mortality in chronic obstructive pulmonary disease (COPD)-related hospitalizations using the nationwide cohort.
We queried the National Inpatient Sample (NIS) (2010-2014) databases to identify adult COPD hospitalizations with arrhythmia. Categorical and continuous variables were compared using Chi-square and Student's t-test/ANOVA. Predictors of any arrhythmia including AF and in-hospital mortality were evaluated by multivariable analyses.
Out of 21,596,342 COPD hospitalizations, 6,480,799 (30%) revealed co-existent arrhythmias including 4,767,401 AF-arrhythmias (22.1%) and 1,713,398 non AF-arrhythmias (7.9%). The AF or non-AF arrhythmia cohort consisted mostly of older (mean age~ 75.8 & 69.1 vs. 67.5 years) white male (53.3% & 51.9% vs. 46.9%) patients compared to those without arrhythmias (p < 0.001). The all-cause mortality (5.7% & 5.2 vs. 2.9%), mean length of stay (LOS) (6.4 & 6.5 vs. 5.3 days), and hospital charges ($52,699.49 & $58,102.39 vs. $41,208.02) were higher with AF and non AF-arrhythmia compared to the non-arrhythmia group (p < 0.001). Comorbidities such as cardiomyopathy (OR 2.11), cardiogenic shock (OR 1.88), valvular diseases (OR 1.60), congestive heart failure (OR 1.48) and pulmonary circulation disorders (OR 1.25) predicted in-hospital arrhythmias. Invasive mechanical ventilation (OR 6.41), cardiogenic shock (OR 5.95), cerebrovascular disease (OR 3.95), septicemia (OR 2.30) and acute myocardial infarction (OR 2.24) predicted higher mortality (p < 0.001) in the COPD-arrhythmia cohort.
About 30% of COPD hospitalizations revealed co-existent arrhythmias (AF 22.1%). All-cause mortality, LOS and hospital charges were significantly higher with arrhythmias. We observed racial and sex-based disparities for arrhythmias and related mortality.
我们旨在使用全国性队列分析慢性阻塞性肺疾病(COPD)相关住院患者心律失常和院内死亡率的负担和预测因素。
我们从国家住院患者样本(NIS)(2010-2014 年)数据库中查询了伴有心律失常的成人 COPD 住院患者。使用卡方检验和学生 t 检验/方差分析比较分类变量和连续变量。使用多变量分析评估了所有心律失常(包括 AF 和院内死亡率)的预测因素。
在 21596342 例 COPD 住院患者中,6480799 例(30%)存在共存心律失常,包括 4767401 例 AF 心律失常(22.1%)和 1713398 例非 AF 心律失常(7.9%)。AF 或非-AF 心律失常组主要由年龄较大(平均年龄~75.8 岁和 69.1 岁 vs. 67.5 岁)的白人男性(53.3% 和 51.9% vs. 46.9%)组成,与无心律失常组相比(p<0.001)。所有原因死亡率(5.7% 和 5.2% vs. 2.9%)、平均住院时间(6.4 天和 6.5 天 vs. 5.3 天)和住院费用($52699.49 和 $58102.39 vs. $41208.02)在 AF 和非-AF 心律失常组中高于无心律失常组(p<0.001)。合并症,如心肌病(OR 2.11)、心源性休克(OR 1.88)、瓣膜疾病(OR 1.60)、充血性心力衰竭(OR 1.48)和肺循环疾病(OR 1.25)预测了院内心律失常。有创性机械通气(OR 6.41)、心源性休克(OR 5.95)、脑血管病(OR 3.95)、败血症(OR 2.30)和急性心肌梗死(OR 2.24)预测了 COPD 心律失常组的死亡率更高(p<0.001)。
约 30%的 COPD 住院患者存在共存心律失常(AF 占 22.1%)。心律失常组的全因死亡率、住院时间和住院费用明显更高。我们观察到心律失常和相关死亡率存在种族和性别差异。